Hematologic supportive care by treatment group
. | BR, n (%) . | R-CHOP/R-CVP, n (%) . | ||||||
---|---|---|---|---|---|---|---|---|
Supportive care therapeutic class . | Supportive care therapeutic class . | |||||||
Cycle . | n . | Erythropoiesis-stimulating agents . | Transfusions . | Granulocyte colony-stimulating factors . | n . | Erythropoiesis-stimulating agents . | Transfusions . | Granulocyte colony-stimulating factors . |
1 | 221 | 0 | 3 (1) | 20 (9) | 215 | 3 (1) | 9 (4) | 55 (26) |
2 | 219 | 1 (<1) | 2 (<1) | 23 (11) | 211 | 2 (<1) | 3 (1) | 62 (29) |
3 | 215 | 1 (<1) | 0 | 29 (13) | 207 | 2 (<1) | 0 | 60 (29) |
4 | 209 | 0 | 1 (<1) | 38 (18) | 201 | 5 (2) | 2 (<1) | 64 (32) |
5 | 206 | 0 | 1 (<1) | 36 (17) | 201 | 3 (1) | 3 (1) | 65 (32) |
6 | 203 | 1 (<1) | 3 (1) | 29 (14) | 196 | 3 (2) | 1 (<1) | 60 (31) |
Any | 221 | 4 (2) | 10 (5) | 63 (29) | 215 | 9 (4) | 15 (7) | 92 (43)* |
. | BR, n (%) . | R-CHOP/R-CVP, n (%) . | ||||||
---|---|---|---|---|---|---|---|---|
Supportive care therapeutic class . | Supportive care therapeutic class . | |||||||
Cycle . | n . | Erythropoiesis-stimulating agents . | Transfusions . | Granulocyte colony-stimulating factors . | n . | Erythropoiesis-stimulating agents . | Transfusions . | Granulocyte colony-stimulating factors . |
1 | 221 | 0 | 3 (1) | 20 (9) | 215 | 3 (1) | 9 (4) | 55 (26) |
2 | 219 | 1 (<1) | 2 (<1) | 23 (11) | 211 | 2 (<1) | 3 (1) | 62 (29) |
3 | 215 | 1 (<1) | 0 | 29 (13) | 207 | 2 (<1) | 0 | 60 (29) |
4 | 209 | 0 | 1 (<1) | 38 (18) | 201 | 5 (2) | 2 (<1) | 64 (32) |
5 | 206 | 0 | 1 (<1) | 36 (17) | 201 | 3 (1) | 3 (1) | 65 (32) |
6 | 203 | 1 (<1) | 3 (1) | 29 (14) | 196 | 3 (2) | 1 (<1) | 60 (31) |
Any | 221 | 4 (2) | 10 (5) | 63 (29) | 215 | 9 (4) | 15 (7) | 92 (43)* |
Erythropoiesis-stimulating agents: epoetin alfa and darbepoetin alfa; transfusions: blood cells, packed human platelets, and red blood cells; and granulocyte colony-stimulating factors: pegfilgrastim, filgrastim, and lenograstim.
P = .0018, Pearson’s χ-square test; P values not analyzed by cycle.